Premium
Catheter Ablation of Ventricular Tachycardia in Patients With MitraClip Device: Preliminary Findings
Author(s) -
HAEGELI LAURENT M.,
D'ANGELO GIUSEPPE,
TREVISI NICOLA,
STELLA STEFANO,
BREITENSTEIN ALEXANDER,
DURU FIRAT,
BRUNCKHORST CORINNA,
DELLA BELLA PAOLO
Publication year - 2017
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/jce.13180
Subject(s) - medicine , mitraclip , fluoroscopy , ablation , catheter ablation , catheter , cardiology , ventricle , ejection fraction , coronary sinus , mitral regurgitation , percutaneous , ventricular tachycardia , surgery , heart failure
VT Ablation in MitraClip Patients Introduction Patients with mitral regurgitation are increasingly treated by percutaneous implantation of a MitraClip device (Abbott Park, IL, USA). We investigate the feasibility and safety of the transmitral catheter route for catheter ablation of ventricular tachycardia (VT) in these patients. Methods The mitral valve with the MitraClip in situ was crossed under transesophageal 3‐dimensional echocardiographic and fluoroscopic guidance using a steerable sheath for ablation of the left ventricle. Results Five patients (all males, median age 74.0 ± 16.0 years) who had previously a MitraClip implanted were referred for catheter ablation of VT. The left ventricular ejection fraction was 29.0% ± 24.0%. One patient had both an atrial septal defect and a left atrial appendage occluder device in addition to a MitraClip. The duration between MitraClip implantation and ablation was 1019.0 ± 783.0 days. After transseptal puncture, ablation catheter was successfully steered through the mitral valve with the use of fluoroscopy. A complete high‐density map of the substrate in sinus rhythm could be obtained in all patients using multipolar mapping catheters. In 1 patient, mapping was carried out using a mini‐basket catheter. Procedural endpoints, noninducibility of all VTs, and abolition of all late potentials were achieved in all patients. Procedure time was 255.0 ± 52.5 minute, fluoroscopy time was 23.0 ± 7.3, and the radiation dose was 61.0 ± 37.5 Gycm 2 . No mitral insufficiency or worsening of regurgitation was documented after the procedure. Conclusions This is the first report demonstrating the feasibility and safety of VT ablation in patients with a MitraClip device using the anterograde transmitral catheter route.